As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

Novavax, Inc. (Nasdaq: NVAX) today announced preliminary results from the SHIELD-Utah study (Study of Healthcare Workers and ...

Novavax (NasdaqGS:NVAX) recently announced promising preliminary results from the SHIELD-Utah study, which highlighted fewer and less severe reactogenicity symptoms for its COVID-19 Vaccine, ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

Workers who received Novavax reported 12.5% fewer local reactions than those who received the Pfizer vaccine. Average hours ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

Shares in US biotech Novavax fell more than 20% before the weekend, following remarks from health and human services ...

The former top vaccines official at the Food and Drug Administration criticized Health and Human Services Secretary Robert F.

Complex Pandemic Accord negotiations have been under way since 2021, with 13 formal meetings and numerous informal sessions.

Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...